Global Biostorage Service Market Size is Expected to Reach USD 655.81 Million by 2026

Biostorage service is a specialized facility and technical service designed for the long-term preservation of biological samples, such as blood, serum, DNA, RNA, tissue samples, cell lines, and microbial specimens. The service uses low-temperature storage (e.g., -20°C, -80°C freezers, or liquid nitrogen tanks) and strict environmental monitoring to maintain the biological activity and integrity of samples over extended periods. Biostorage services are widely used in pharmaceutical research, clinical trials, genetic studies, vaccine development, and bioproduct manufacturing. These services typically include sample registration, tracking management, retrieval and distribution, and security measures, ensuring traceability, easy access, and regulatory compliance, providing reliable support for research and clinical applications.

Biostorage Service Market Overview
According to WENKH research statistics, the Biostorage Service market size is set to climb from $655.81 million in 2026 to $1,658.22 million by 2033, achieving a compound annual growth rate (CAGR) of around 14.17%. Driven primarily by the advancement of precision medicine and the deepening of biopharmaceutical research and development, the maturation of gene sequencing as well as cell and gene therapy technologies, alongside the continuous expansion of new drug development and clinical studies, is leading to a simultaneous increase in the collection of biological samples and the demand for long-term compliant storage. This, in turn, is steadily driving the growth of specialized biostorage service demand.

Biostorage Service Competitive Landscape
According to WENKH's in-depth research, key market players of Biostorage Service include Azenta, EPL Archives (VWR), Thermo Fisher Scientific, Precision for Medicine, Kryosphere, Cryoport, Masy BioServices (Alcami), SciSafe (BioLife Solutions), Cenetron (Versiti Clinical Trials), Vigilant Bioservices, Hong Kong Science & Technology Parks, BioArkive, Precision Stability Storage, Goodwill E-health Info, Tescor, Birka BioStorag, Shanghai Biochip, Albetra, etc.
The top three manufacturers account for approximately 38% of the market share.
Tier 1 players, led by Azenta, Thermo Fisher Scientific, and EPL Archives (VWR), command the largest market share and possess extensive infrastructure, technological capabilities, and global client reach.
Tier 2 enterprises include Precision for Medicine, Cryoport, Masy BioServices (Alcami), Kryosphere, SciSafe (BioLife Solutions), Cenetron (Versiti Clinical Trials), and Vigilant Bioservices, representing mid-sized players with significant regional or niche market presence, specialized offerings, or strategic partnerships.
Tier 3 consists of smaller or emerging players such as Hong Kong Science & Technology Parks, BioArkive, Precision Stability Storage, Goodwill E-health Info, Tescor, Birka BioStorag, Shanghai Biochip, and Albetra, which are often focused on specific regions, specialized services, or early-stage expansion.

Biostorage Service Regional Analysis
According to WENKH research statistics, North America remains the largest market globally, in 2026, North America market size is estimated at $269.21 million, accounting for approximately 41.05% of the global share.
The region benefits from a mature biopharmaceutical industry, comprehensive regulatory and payment systems, and a concentration of leading enterprises and research institutions. This has fostered a full-chain service ecosystem covering everything from sample collection to long-term storage, making North America a key hub for the development and global dissemination of biostorage technologies and standards, with many companies using the region as a central base for their global operations.

Biostorage Service Market Segmentation by Type
According to WENKH research statistics, Biostorage Service is mainly subdivided into Room Temperature Storage, Refrigerated Storage, Frozen Storage, Ultra Low Temperature Storage, and Liquid Nitrogen Storage.
Frozen and Ultra Low Temperature Storage are the most widely used mainstream categories, covering the long-term preservation needs of conventional biological samples. Relying on mature technologies and extensive downstream applications, they form a stable market foundation, with service models primarily focused on standardized batch storage, catering to routine sample management in pharmaceutical research and clinical studies.
Liquid Nitrogen Storage is the fastest-growing segment, targeting the long-term preservation of high-value biological samples and meeting the sample management needs of cutting-edge areas such as cell and gene therapies. This segment has higher technological and compliance requirements, and the market is dominated by customized services that expand rapidly alongside innovative therapy development.
Room Temperature and Refrigerated Storage mainly serve as auxiliary solutions for short-term circulation and routine sample management. These markets operate under a light-asset model and, with advances in cold chain technology and the growing demand for end-to-end sample management, are evolving toward highly adaptable integrated services.

Biostorage Service Market Segmentation by Application
According to WENKH research statistics, Biostorage Service is applied to Life Sciences and Medicine, Hospitals, Government and Scientific Research Institutions, the Chemical Industry, and other sectors.
Among these, the life sciences and medicine sector represent the most extensive application, covering the full process of new drug development, biological sample management, and clinical trials. Demand in this sector focuses on high compliance, standardized storage, and full-cycle sample traceability, supporting the global innovation pipeline and providing a stable foundational demand for the industry.
Hospitals are the fastest-growing application area, driven by the increasing requirements of precision medicine and clinical translation. Storage needs for clinical samples, biological products, and cell therapy materials are rapidly expanding, with services characterized by customization and close alignment with clinical workflows, directly promoting the evolution of the industry toward scenario-based, integrated service models.
Government agencies and research institutions primarily rely on public biobanks and research project requirements, providing stable long-term storage orders, while demand in the chemical industry is concentrated on specific biological raw material preservation scenarios, representing a relatively limited application scale.

The above data is from the market analysis report "Global Biostorage Service Market Size, Competition Landscape and Supply Chain Research Report 2026" ( https://www.wenkhresearch.com/reports/biostorage-service-1914655682818334720 )

Wenkh Research Inc.
Address: 1 Market Street, 19th Floor, San Francisco, CA 94105, United States
E-mail: market@wenkh.com
Website: https://www.wenkhresearch.com/

WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.

This release was published on openPR.